Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cornerstone Q1 net revenues down
The company has reported a net income of $1.74m, or $0.07 per diluted share, compared to net income of $5.01m or $0.19 per diluted share, for the same
The company has reported a net income of $1.74m, or $0.07 per diluted share, compared to net income of $5.01m or $0.19 per diluted share, for the same
The double-blind, placebo-controlled, six-week clinical trial (with an active comparator) was conducted in Japan, Korea and Taiwan. Subjects were randomized to four arms – placebo (129 subjects), lurasidone
CYT107 is a critical immune-modulator for immune T-cell recovery and enhancement. The study, known as ELYPSE-7, is a randomised, monocentric, double-blind Phase IIa study evaluating the impact of
The company has reported a net loss of $18.4m, compared to net loss of $16.25m, for the same period last year. The company’s loss from operations was $18.54m,
The company has also treated first patient in the trial. The RPL554 compound is a new bronchodilator/anti-inflammatory drug belonging to a class of drugs known as a mixed
The new label is equipped with a tamper-evident feature in the form of a perforation that provides assurance the autoinjector or pen was not previously opened and that
Almac has implemented biocatalytic technology for metabolite synthesis, isolation and structural identification. Metabolite synthesis is another tool within selectAZyme’s service providing access to both oxidative and glycosylated products.
Paclical is indicated for ovarian cancer and lung cancer. Oasmia has developed a water soluble formulation of Paclitaxel with the retinoid based platform XR-17. Oasmia claims Paclitaxel does
As part of the agreement, BioFocus will use its SilenceSelect target discovery platform to deliver validated targets to enhance the Astellas neurology pipeline. BioFocus will receive research funding
The PBS 3 bioreactor with patented Air-Wheel system employs a low shear, pneumatic mixing mechanism, and has a 3-liter maximum working volume capacity. The feature of fast mixing